Cyclodextrins: improving the therapeutic response of analgesic drugs: a patent review

Bibliography

• Loftsson T, Jarho P, Másson M, Järvinen T. Cyclodextrins in drug delivery. Expert Opin Drug Deliv 2005;2:335-51
   PubMed Web of Science ®Google Scholar
• Zhang J, Ma PX. Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective. Adv Drug Deliv Rev 2013;65:1215-33
   PubMed Web of Science ®Google Scholar
• Tiwari G, Tiwari R, Rai A. Cyclodextrins in delivery systems: Applications. J Pharm Bioallied Sci 2010;2:72
   PubMedGoogle Scholar
• Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem 2004;39:1033-46
   Web of Science ®Google Scholar
• Khan NA, Durakshan M. Cyclodextrin: an overview. Int J Bioassays 2013;2:858-65
   Google Scholar
• Stella VJ, He Q. Cyclodextrins. Toxicol Pathol 2008;36:30-42
   PubMed Web of Science ®Google Scholar
• Pinho E, Grootveld M, Soares G, Henriques M. Cyclodextrins as encapsulation agents for plant bioactive compounds. Carbohydr Polym 2014;101:121-35
   PubMed Web of Science ®Google Scholar
• Arima H, Motoyama K, Irie T. Recent findings on safety profiles of cyclodextrins, cyclodextrin conjugates, and polypseudorotaxanes. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine; 2011
   Google Scholar
• Kurkov SV, Loftsson T. Cyclodextrins. Int J Pharm 2013;453:167-80
   PubMed Web of Science ®Google Scholar
• Arun R, Ashok Kumar CK, Sravanthi VVNSS. Cyclodextrins as drug carrier molecule: a review. Sci Pharm 2008;76:567-98
   Google Scholar
• Woolf CJ. Overcoming obstacles to developing new analgesics. Nat Med 2010;16:1241-7
   PubMed Web of Science ®Google Scholar
• Kissin I. The development of new analgesics over the past 50 years: a lack of real breakthrough drugs. Anesth Analg 2010;110:780-9
   PubMed Web of Science ®Google Scholar
• Otonomy, Inc. Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders. WO 2010074992; 2010
   Google Scholar
• Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007;329:1-11
   PubMed Web of Science ®Google Scholar
• Szente L, Szejtli J. Cyclodextrins as food ingredients. Trends Food Sci Technol 2004;15:137-42
   Web of Science ®Google Scholar
• Tao F, Hill LE, Peng Y, Gomes CL. Synthesis and characterization of β-cyclodextrin inclusion complexes of thymol and thyme oil for antimicrobial delivery applications. LWT - Food Sci Technol 2014;59:247-55
   Web of Science ®Google Scholar
• Chiesi Farmaceutici S.p.A. New compounds having antiinflammatory activity, obtained by complexation with beta-cyclodextrin, and pharmaceutical compositions containing them. IT19840019735 19840222; 1985
   Google Scholar
• Chiesi Farmaceutici S.p.A. Compounds having antiinflammatory activity, obtained by complexation of piroxican with beta -cyclodextrin, and pharmaceutical compositions containing them. US4603123; 1986
   Google Scholar
• Zmitek J, Verhnjak K, Fercej-Temeljotov D, et al. Inclusion complexes of racemic ibuproxam and of optically active ibuproxam with cyclodextrin derivatives, process for the preparation thereof, pharmaceutical preparations containing these inclusion complexes or containing optically active s-(+)-ibuproxam, and use thereof. WO95/07076; 1995
   Google Scholar
• Wain, CP et al A.A. Thornton & Co. Inclusion complex of an opioid peptide with cyclodextrin. EP1174152; 2006
   Google Scholar
• Quintans-Júnior LJ. Método de obtenção de complexos de inclusão de Ocimum basilicum, complexos de inclusão obtidos e seu uso no tratamento de dor. BR2020130256773; 2013
   Google Scholar
• Quintans-Júnior LJ, et al. Complexos de inclusão contendo óleo essencial de lippia grata e β-ciclodextrina para o tratamento de dor e inflamação e método de obtenção dos mesmo. BR1020130256781; 2013
   Google Scholar
• Quintans-Júnior LJ, et al. Metodos de obtenção de complexos de inclusão de linalol, complexos de inclusão obtidos e seu uso no tratamento de dor. BR1020130300268; 2013
   Google Scholar
• Ottinger EA, Kao ML, Carrillo-Carrasco N, et al. Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease. Curr Top Med Chem 2014;14:330-9
   PubMed Web of Science ®Google Scholar
• Cohen G, Dubois J-L. Neue komplexe der tiaprofensäure oder ihrer unlöslichen oder zum teil löslichen ester mit den cyclodextrinen oder ihren derivaten. EP 0449722, 1991
   Google Scholar
• Univ California. Cyclodextrin complexes for neuraxial administration of drugs. WO 02256; 1992
   Google Scholar
• Borgbjerg FM. The use of 2-hydroxypropyl-β-cyclodextrin (cdex) for preparing an opioid analgesic preparation for intramuscular or subcutaneous administration. WO 95/05197; 1995
   Google Scholar
• Amorepacific Corp. Composition pharmaceutique contenant un derive de thiouree et presentant une solubilite et une biodisponibilite ameliorees. WO 2005/040106; 2003
   Google Scholar
• Altergon SA. Injectable pharmaceutical compositions comprising sodium diclofenac, beta-cyclodextrin and a polysorbate. EP1609481; 2005
   Google Scholar
• Javelin Pharmaceuticals, Inc. Formulations of low dose diclofenac and beta-cyclodextrin. MX2008012495; 2009
   Google Scholar
• Wright C, Carr DB, Mermelstein FH. Formulations of low dose diclofenac and beta-cyclodextrin. US0218247; 2011
   Google Scholar
• Javelin Pharmaceuticals, Inc. Formulations of low dose diclofenac and beta-cyclodextrin. EP2522344; 2012
   Google Scholar
• Javelin Pharmaceuticals, Inc. Formulations of low dose diclofenac and beta-cyclodextrin. US0107209; 2014
   Google Scholar
• Hospira, Inc. Methods of treating pain. WO013076; 2013
   Google Scholar
• Giambrocono & C. S.p.A. A complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof. WO 2013/004462; 2013
   Google Scholar
• Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov 2004;3:1023-35
   PubMed Web of Science ®Google Scholar
• Agrawal Gupta V. Cyclodextrins – a review on pharmaceutical application for drug delivery. Int J Pharm Front Res 2012;2:95-112
   Google Scholar
• Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004;21:201-30
   PubMed Web of Science ®Google Scholar
• Carter GT, Duong V, Ho S, et al. Side effects of commonly prescribed analgesic medications. Phys Med Rehabil Clin N Am 2014;25:457-70
   PubMed Web of Science ®Google Scholar
• Scarpignato C. Piroxicam-β-cyclodextrin: a GI safer piroxicam. Curr Med Chem 2013;20:2415-37
   PubMed Web of Science ®Google Scholar
• Daniels S, Melson T, Hamilton DA, et al. Analgesic efficacy and safety of a novel injectable formulation of diclofenac compared with intravenous ketorolac and placebo after orthopedic surgery: a multicenter, randomized, double-blinded, multiple-dose trial. Clin J Pain 2013;29:655-63
   PubMed Web of Science ®Google Scholar
• Quintans J de SS, Menezes PP, Santos MRV, et al. Improvement of p-cymene antinociceptive and anti-inflammatory effects by inclusion in β-cyclodextrin. Phytomedicine Int J Phytother Phytopharm 2013;20:436-40
   PubMed Web of Science ®Google Scholar
• Quintans-Júnior LJ, Barreto RSS, Menezes PP, et al. β-Cyclodextrin-complexed (-)-linalool produces antinociceptive effect superior to that of (-)-linalool in experimental pain protocols. Basic Clin Pharmacol Toxicol 2013;113:167-72
   PubMed Web of Science ®Google Scholar
• Mermelstein F, Hamilton DA, Wright C, et al. Single-dose and multiple-dose pharmacokinetics and dose proportionality of intravenous and intramuscular HPβCD-diclofenac (Dyloject) compared with other diclofenac formulations. Pharmacotherapy 2013;33:1012-21
   PubMed Web of Science ®Google Scholar
• Gan TJ, Daniels SE, Singla N, et al. A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesth Analg 2012;115:1212-20
   PubMed Web of Science ®Google Scholar
• Guimarães AG, Quintans JSS, Quintans LJJr. Monoterpenes with analgesic activity--a systematic review. Phytother Res PTR 2013;27:1-15
   PubMed Web of Science ®Google Scholar
• Guimarães AG, Serafini MR, Quintans-Júnior LJ. Terpenes and derivatives as a new perspective for pain treatment: a patent review. Expert Opin Ther Pat 2014;24:243-65
   PubMed Web of Science ®Google Scholar
• Quintans JSS, Antoniolli AR, Almeida JRGS, et al. Natural products evaluated in neuropathic pain models - a systematic review. Basic Clin Pharmacol Toxicol 2014;114(6):442-50
   PubMed Web of Science ®Google Scholar
• Siqueira-Lima PS, Araújo AAS, Lucchese AM, et al. β-cyclodextrin complex containing Lippia grata leaf essential oil reduces orofacial nociception in mice - evidence of possible involvement of descending inhibitory pain modulation pathway. Basic Clin Pharmacol Toxicol 2014;114:188-96
   PubMed Web of Science ®Google Scholar
• Marques HMC. A review on cyclodextrin encapsulation of essential oils and volatiles. Flavour Fragr J 2010;25:313-26
   Web of Science ®Google Scholar